PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 340,500
+13,500 (4.13%)
Jul 21, 2026, 2:40 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.4 trillion as of July 20, 2026. Its market cap has decreased by -42.33% in one year.
Market Cap
3.40T
Enterprise Value
3.02T
Revenue
565.48B
Ranking
n/a
PE Ratio
20.58
Stock Price
340,500.00
ChartMarket Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.40T, an increase of 236.62%. That is a compound annual growth rate of 11.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 3.40T | -18.86% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.26T |
| Celltrion | 39.58T |
| ALTEOGEN | 14.44T |
| Samsung Epis Holdings | 9.27T |
| Sam Chun Dang Pharm. | 4.31T |
| HLB Co., Ltd. | 4.06T |
| ABL Bio | 3.93T |
| LigaChem Biosciences | 3.58T |